Provectus Financial Statements From 2010 to 2024

PVCTDelisted Stock  USD 0.11  0.00  0.00%   
Provectus Biopharmaceutica financial statements provide useful quarterly and yearly information to potential Provectus Biopharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Provectus Biopharmaceutica financial statements helps investors assess Provectus Biopharmaceutica's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Provectus Biopharmaceutica's valuation are summarized below:
Provectus Biopharmaceuticals does not presently have any trending fundamental ratios for analysis.
Check Provectus Biopharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Provectus main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Provectus financial statements analysis is a perfect complement when working with Provectus Biopharmaceutica Valuation or Volatility modules.
  
This module can also supplement various Provectus Biopharmaceutica Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Provectus Cash Flow From Operations Analysis

Provectus Biopharmaceutica's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Operating Cash Flow

 = 

EBITDA

-

Taxes

More About Cash Flow From Operations | All Equity Analysis

Current Provectus Biopharmaceutica Cash Flow From Operations

    
  (1.01 M)  
Most of Provectus Biopharmaceutica's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Provectus Biopharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition

In accordance with the recently published financial statements, Provectus Biopharmaceuticals has (1.01 Million) in Cash Flow From Operations. This is 100.19% lower than that of the Pharmaceuticals sector and 101.62% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.1% higher than that of the company.

Provectus Biopharmaceutica Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Provectus Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Provectus Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Provectus Biopharmaceutica competition to find correlations between indicators driving Provectus Biopharmaceutica's intrinsic value. More Info.
Provectus Biopharmaceuticals is considered to be number one stock in price to sales category among related companies. It is considered to be number one stock in current ratio category among related companies . The ratio of Price To Sales to Current Ratio for Provectus Biopharmaceuticals is about  207.20 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Provectus Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Provectus Biopharmaceutica's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Provectus Biopharmaceutica's earnings, one of the primary drivers of an investment's value.

About Provectus Biopharmaceutica Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Provectus Biopharmaceutica income statement, its balance sheet, and the statement of cash flows. Provectus Biopharmaceutica investors use historical funamental indicators, such as Provectus Biopharmaceutica's revenue or net income, to determine how well the company is positioned to perform in the future. Although Provectus Biopharmaceutica investors may use each financial statement separately, they are all related. The changes in Provectus Biopharmaceutica's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Provectus Biopharmaceutica's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Provectus Biopharmaceutica Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Provectus Biopharmaceutica. Please read more on our technical analysis and fundamental analysis pages.
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee. Provectus Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Provectus Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Provectus Biopharmaceutica's short interest history, or implied volatility extrapolated from Provectus Biopharmaceutica options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Provectus Biopharmaceutica using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Provectus OTC Stock

If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets